<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:fe934c02-0f8a-4ed7-a34b-dc83a10c16ca,g:614f7be4-2a92-4ccb-bdb9-9746f3ab660f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cccc-20231231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6c7e487f-4171-45ea-95b0-f1ca9b02c94a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e404ff0c-1745-44e5-99e2-1196ccf89932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6c7e487f-4171-45ea-95b0-f1ca9b02c94a" xlink:to="loc_us-gaap_PreferredStockValue_e404ff0c-1745-44e5-99e2-1196ccf89932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_28d4ad70-637a-458b-8123-4a91ca87fb87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6c7e487f-4171-45ea-95b0-f1ca9b02c94a" xlink:to="loc_us-gaap_CommonStockValue_28d4ad70-637a-458b-8123-4a91ca87fb87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_374d3e41-c146-4a0f-8a54-da6789ebe232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6c7e487f-4171-45ea-95b0-f1ca9b02c94a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_374d3e41-c146-4a0f-8a54-da6789ebe232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_75b50a61-bc49-49fa-9671-e9282a77818e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6c7e487f-4171-45ea-95b0-f1ca9b02c94a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_75b50a61-bc49-49fa-9671-e9282a77818e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8d921fef-9e74-4333-84e4-2af4dd501a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6c7e487f-4171-45ea-95b0-f1ca9b02c94a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8d921fef-9e74-4333-84e4-2af4dd501a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2210826e-c0a4-4a10-8839-ae391c5d8307" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_12a00156-fd6f-44d3-ae6d-9fac6bdab332" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2210826e-c0a4-4a10-8839-ae391c5d8307" xlink:to="loc_us-gaap_AssetsCurrent_12a00156-fd6f-44d3-ae6d-9fac6bdab332" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_1a1e797b-b993-4ef5-9873-3700478b10d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2210826e-c0a4-4a10-8839-ae391c5d8307" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_1a1e797b-b993-4ef5-9873-3700478b10d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_854b232a-7f7b-47fc-aa7a-f5aad64904c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2210826e-c0a4-4a10-8839-ae391c5d8307" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_854b232a-7f7b-47fc-aa7a-f5aad64904c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bfa1e507-581a-4a2e-9e17-35345279305e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2210826e-c0a4-4a10-8839-ae391c5d8307" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bfa1e507-581a-4a2e-9e17-35345279305e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_e0e4c24c-1513-45e8-93d4-1097d7022e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2210826e-c0a4-4a10-8839-ae391c5d8307" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_e0e4c24c-1513-45e8-93d4-1097d7022e1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_136e5967-c191-45d6-96a9-b512617116cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2210826e-c0a4-4a10-8839-ae391c5d8307" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_136e5967-c191-45d6-96a9-b512617116cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c2b535af-c3a7-4eb2-b3b8-20cfb30c7db5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce0fa652-9e15-4655-8dce-6d7c27d1a3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2b535af-c3a7-4eb2-b3b8-20cfb30c7db5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce0fa652-9e15-4655-8dce-6d7c27d1a3b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_fdf61402-e744-474a-87c4-601d7cd6e934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2b535af-c3a7-4eb2-b3b8-20cfb30c7db5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_fdf61402-e744-474a-87c4-601d7cd6e934" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_aab03001-5948-42ca-b43b-a13c35d91f85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2b535af-c3a7-4eb2-b3b8-20cfb30c7db5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_aab03001-5948-42ca-b43b-a13c35d91f85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7579f675-fdd4-4f34-8f77-ff9321033678" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2b535af-c3a7-4eb2-b3b8-20cfb30c7db5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7579f675-fdd4-4f34-8f77-ff9321033678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e4b31abf-58a7-4148-804b-e7a691e922ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_29c1db0d-aebd-4b26-8eef-56146e1c8220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e4b31abf-58a7-4148-804b-e7a691e922ba" xlink:to="loc_us-gaap_Liabilities_29c1db0d-aebd-4b26-8eef-56146e1c8220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ce289de0-21bd-4a14-92cd-86f8bba45b63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e4b31abf-58a7-4148-804b-e7a691e922ba" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ce289de0-21bd-4a14-92cd-86f8bba45b63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d8912c16-eb13-4102-9784-f486f223d7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e4b31abf-58a7-4148-804b-e7a691e922ba" xlink:to="loc_us-gaap_StockholdersEquity_d8912c16-eb13-4102-9784-f486f223d7b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fe35120d-4ead-4adc-a1b8-784188ed9783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_42e624f0-3b19-4c87-a824-9ea921419fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fe35120d-4ead-4adc-a1b8-784188ed9783" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_42e624f0-3b19-4c87-a824-9ea921419fcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_746f51c1-0deb-417d-869e-b7a0bd7c57be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fe35120d-4ead-4adc-a1b8-784188ed9783" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_746f51c1-0deb-417d-869e-b7a0bd7c57be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_73d46009-c42d-4d10-940c-9c0dd2701dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fe35120d-4ead-4adc-a1b8-784188ed9783" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_73d46009-c42d-4d10-940c-9c0dd2701dd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3d67664e-7644-4387-ba6d-09e97ca808a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fe35120d-4ead-4adc-a1b8-784188ed9783" xlink:to="loc_us-gaap_AccountsPayableCurrent_3d67664e-7644-4387-ba6d-09e97ca808a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_124ba1c5-95ac-4d33-b241-9b49aea21a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fe35120d-4ead-4adc-a1b8-784188ed9783" xlink:to="loc_us-gaap_LongTermDebtCurrent_124ba1c5-95ac-4d33-b241-9b49aea21a5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a399e561-cbe3-47a7-b05d-ed7043f680bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_44ecb7db-0733-40de-ad2c-538cdd4c24b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a399e561-cbe3-47a7-b05d-ed7043f680bc" xlink:to="loc_us-gaap_LiabilitiesCurrent_44ecb7db-0733-40de-ad2c-538cdd4c24b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_98a1c20a-0cd4-4613-990f-22411f41c195" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a399e561-cbe3-47a7-b05d-ed7043f680bc" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_98a1c20a-0cd4-4613-990f-22411f41c195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0a246a19-13bf-481f-8aa7-58136e66a4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a399e561-cbe3-47a7-b05d-ed7043f680bc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0a246a19-13bf-481f-8aa7-58136e66a4c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c888a1dc-3675-4505-93ed-a82eb7f55dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a399e561-cbe3-47a7-b05d-ed7043f680bc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c888a1dc-3675-4505-93ed-a82eb7f55dc0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="cccc-20231231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0237402a-bcb9-42c1-af58-df5f8a27c8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bd86735f-4a6d-4a42-aadb-2e28fe203e68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0237402a-bcb9-42c1-af58-df5f8a27c8f2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bd86735f-4a6d-4a42-aadb-2e28fe203e68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_243f182b-f5ad-41bd-a7b3-fb5831f9829e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0237402a-bcb9-42c1-af58-df5f8a27c8f2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_243f182b-f5ad-41bd-a7b3-fb5831f9829e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_42775ca6-e8be-4cd9-be43-052edb0d6666" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c7640a9e-6cb4-4d3c-a38f-81cb878ce116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_42775ca6-e8be-4cd9-be43-052edb0d6666" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c7640a9e-6cb4-4d3c-a38f-81cb878ce116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0cd65eb7-6bf5-4132-a295-4bed88e2257a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_42775ca6-e8be-4cd9-be43-052edb0d6666" xlink:to="loc_us-gaap_OperatingExpenses_0cd65eb7-6bf5-4132-a295-4bed88e2257a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_53dbb42c-752c-4d5d-ad53-7abbde1db204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_983fe227-da10-43d1-9d2b-bb46d218c898" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_53dbb42c-752c-4d5d-ad53-7abbde1db204" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_983fe227-da10-43d1-9d2b-bb46d218c898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d69920f0-d282-452c-ae0d-2f1666c6eb73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_53dbb42c-752c-4d5d-ad53-7abbde1db204" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d69920f0-d282-452c-ae0d-2f1666c6eb73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bcab0b2c-ba24-4f9b-8de9-6179038f3b45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1afa770c-a28c-45bc-80d0-2fdcccabcfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bcab0b2c-ba24-4f9b-8de9-6179038f3b45" xlink:to="loc_us-gaap_NetIncomeLoss_1afa770c-a28c-45bc-80d0-2fdcccabcfbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_40ecedd8-52cf-48b2-8979-4d7e7661fa2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bcab0b2c-ba24-4f9b-8de9-6179038f3b45" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_40ecedd8-52cf-48b2-8979-4d7e7661fa2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b41a736a-809a-4455-9b98-e6946916798c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_fd4fd5ea-f272-43a2-bbd7-1e88511b167c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b41a736a-809a-4455-9b98-e6946916798c" xlink:to="loc_us-gaap_InterestAndOtherIncome_fd4fd5ea-f272-43a2-bbd7-1e88511b167c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty_2fdfd344-765b-4ff0-ba95-7d076bc8fb37" xlink:href="cccc-20231231.xsd#cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b41a736a-809a-4455-9b98-e6946916798c" xlink:to="loc_cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty_2fdfd344-765b-4ff0-ba95-7d076bc8fb37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e82b882a-26b6-4131-ab9c-ee361925b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b41a736a-809a-4455-9b98-e6946916798c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e82b882a-26b6-4131-ab9c-ee361925b79a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c8636b28-ba7f-428a-8cfe-75e20d2cc766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0322c268-bf31-4339-abe0-da67bdbd8469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c8636b28-ba7f-428a-8cfe-75e20d2cc766" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0322c268-bf31-4339-abe0-da67bdbd8469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fe79dc4d-e1fa-447c-9eaf-30fb0144ffa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c8636b28-ba7f-428a-8cfe-75e20d2cc766" xlink:to="loc_us-gaap_OperatingIncomeLoss_fe79dc4d-e1fa-447c-9eaf-30fb0144ffa7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cccc-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a3c20b85-7102-4d2a-9929-b6e1ff8be5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d1c35203-931b-4a87-a9cf-2f0a1640d436" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a3c20b85-7102-4d2a-9929-b6e1ff8be5b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d1c35203-931b-4a87-a9cf-2f0a1640d436" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed58b44b-5d48-4678-934b-f0e3788f1519" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a3c20b85-7102-4d2a-9929-b6e1ff8be5b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed58b44b-5d48-4678-934b-f0e3788f1519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17b5e030-03bc-4708-b3e9-b33cbb8b6f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a3c20b85-7102-4d2a-9929-b6e1ff8be5b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17b5e030-03bc-4708-b3e9-b33cbb8b6f60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_216ef01d-36a4-4616-8e50-7bdff9f1b7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_216ef01d-36a4-4616-8e50-7bdff9f1b7d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c47aaf81-9e03-457f-950a-3435a731a001" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_NetIncomeLoss_c47aaf81-9e03-457f-950a-3435a731a001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_fc7e7bc9-0581-4827-82d1-a8837e377acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_fc7e7bc9-0581-4827-82d1-a8837e377acb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cbedeaf4-268b-4c38-94bb-4d6f8a837e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cbedeaf4-268b-4c38-94bb-4d6f8a837e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_104b529f-65d1-4338-9ea3-bc119aee2ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_ShareBasedCompensation_104b529f-65d1-4338-9ea3-bc119aee2ea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_77efbc88-486c-4fb3-bdff-6f4e045e7ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_77efbc88-486c-4fb3-bdff-6f4e045e7ed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f469a7e4-01bf-458f-871d-55779ff41d44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f469a7e4-01bf-458f-871d-55779ff41d44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_be70c466-789d-4b57-baca-5302ff58bfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_be70c466-789d-4b57-baca-5302ff58bfa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_ca01e0f1-3aae-4165-bbae-4ea4f2be70e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_ca01e0f1-3aae-4165-bbae-4ea4f2be70e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_86400331-3858-485d-97bd-7649922119ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_86400331-3858-485d-97bd-7649922119ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c377016c-b6f9-4e3e-afa9-0cc4a4268b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_DepreciationAndAmortization_c377016c-b6f9-4e3e-afa9-0cc4a4268b9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_91ffe906-e3dd-4b03-965d-49bef08213e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_91ffe906-e3dd-4b03-965d-49bef08213e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9f9f388d-8fdd-49f8-94aa-7c5c111edf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9f9f388d-8fdd-49f8-94aa-7c5c111edf5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cf7f5168-906b-4862-b8ac-381db08bf655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3bf333a3-7cdd-4def-858a-8bcc8ddb1257" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cf7f5168-906b-4862-b8ac-381db08bf655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d96fac73-086d-48e5-8576-304284a36676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_57f2dd82-0ab5-425b-8bc4-5018943afb95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d96fac73-086d-48e5-8576-304284a36676" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_57f2dd82-0ab5-425b-8bc4-5018943afb95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_bacb04a6-11db-40b4-bcc0-fecf081b3a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d96fac73-086d-48e5-8576-304284a36676" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_bacb04a6-11db-40b4-bcc0-fecf081b3a4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a0eb2d67-0c13-463c-af45-637ddc75b6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d96fac73-086d-48e5-8576-304284a36676" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a0eb2d67-0c13-463c-af45-637ddc75b6b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3037280-2910-4d74-a014-3092fb390971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ceb8c229-8127-45d2-ac31-177d13938275" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3037280-2910-4d74-a014-3092fb390971" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ceb8c229-8127-45d2-ac31-177d13938275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_94e90656-bcb8-47e0-b59d-285934a290ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3037280-2910-4d74-a014-3092fb390971" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_94e90656-bcb8-47e0-b59d-285934a290ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ac85da84-9d67-4ac1-8f48-791e41046c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3037280-2910-4d74-a014-3092fb390971" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ac85da84-9d67-4ac1-8f48-791e41046c70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_7a719ef6-fc1f-4ece-ad8b-fa5fa9d60108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3037280-2910-4d74-a014-3092fb390971" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_7a719ef6-fc1f-4ece-ad8b-fa5fa9d60108" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_72ff7b31-bef3-4c3e-ac5d-e575ff2ab667" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d3037280-2910-4d74-a014-3092fb390971" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_72ff7b31-bef3-4c3e-ac5d-e575ff2ab667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6fc3ec1-b63a-4686-b75b-ccd025fb000d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_7e7e254a-3b37-4970-a1e3-5576a949f972" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6fc3ec1-b63a-4686-b75b-ccd025fb000d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_7e7e254a-3b37-4970-a1e3-5576a949f972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d1357c39-0867-4b1d-b649-e211ce32bca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6fc3ec1-b63a-4686-b75b-ccd025fb000d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d1357c39-0867-4b1d-b649-e211ce32bca1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/FairvaluemeasurementsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#FairvaluemeasurementsDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/FairvaluemeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2e6e2785-63f0-4cf5-8cd8-1c7ebf5a9fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a1398820-4ae6-4eef-9088-3703909da468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2e6e2785-63f0-4cf5-8cd8-1c7ebf5a9fa3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a1398820-4ae6-4eef-9088-3703909da468" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_0a558cb6-b868-436e-9406-1d5c3599c0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_2e6e2785-63f0-4cf5-8cd8-1c7ebf5a9fa3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_0a558cb6-b868-436e-9406-1d5c3599c0ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_a7146c58-369f-4c9d-b395-275ee63944ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_08c26250-9167-4cca-bb85-643e2b81696e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_a7146c58-369f-4c9d-b395-275ee63944ae" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_08c26250-9167-4cca-bb85-643e2b81696e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent_bcda46ee-bc30-4463-b055-1f04f63eca96" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_a7146c58-369f-4c9d-b395-275ee63944ae" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent_bcda46ee-bc30-4463-b055-1f04f63eca96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent_e6aed186-f026-4087-a5d5-305ebb0601bc" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_a7146c58-369f-4c9d-b395-275ee63944ae" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent_e6aed186-f026-4087-a5d5-305ebb0601bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_c0797d42-0527-4a0d-8b72-9d906dfbd669" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_421eacd2-7d92-4e50-8a24-d25357a2f736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_c0797d42-0527-4a0d-8b72-9d906dfbd669" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_421eacd2-7d92-4e50-8a24-d25357a2f736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_bdec4ed5-ec87-470c-9cfb-462d76579313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_c0797d42-0527-4a0d-8b72-9d906dfbd669" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_bdec4ed5-ec87-470c-9cfb-462d76579313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_851c6274-eead-4271-870d-0eeaf996f4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_dfd1b6a8-7fb0-4b56-a59a-76b05de509b9" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_851c6274-eead-4271-870d-0eeaf996f4b3" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_dfd1b6a8-7fb0-4b56-a59a-76b05de509b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_53a1d614-90bd-4020-98de-c0f2ebf0d328" xlink:href="cccc-20231231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_851c6274-eead-4271-870d-0eeaf996f4b3" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_53a1d614-90bd-4020-98de-c0f2ebf0d328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_8e0833db-adb9-4c76-a835-bc0e43cefb09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_851c6274-eead-4271-870d-0eeaf996f4b3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_8e0833db-adb9-4c76-a835-bc0e43cefb09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1" xlink:type="simple" xlink:href="cccc-20231231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_be7aa561-9ae8-4d2a-9d58-1220f54fcb44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_754d3f80-685f-4015-acf9-977e46c42cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_be7aa561-9ae8-4d2a-9d58-1220f54fcb44" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_754d3f80-685f-4015-acf9-977e46c42cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4ce01e81-817b-4676-b25f-ed9fac68e081" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_be7aa561-9ae8-4d2a-9d58-1220f54fcb44" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4ce01e81-817b-4676-b25f-ed9fac68e081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_161a4423-f8a4-4796-992d-a690d079711e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_be7aa561-9ae8-4d2a-9d58-1220f54fcb44" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_161a4423-f8a4-4796-992d-a690d079711e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d7563049-6b77-41f0-ab04-43ce16993135" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_f2db7ab1-85a6-4a3d-a78c-081243f92f09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d7563049-6b77-41f0-ab04-43ce16993135" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_f2db7ab1-85a6-4a3d-a78c-081243f92f09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_62d8174e-36d2-4e3f-af35-df2b1e321972" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d7563049-6b77-41f0-ab04-43ce16993135" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_62d8174e-36d2-4e3f-af35-df2b1e321972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2fbc79da-51c6-40cb-b003-31cc9e92435c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_3d75b332-8806-4cf5-bb28-98e706ab66fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2fbc79da-51c6-40cb-b003-31cc9e92435c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_3d75b332-8806-4cf5-bb28-98e706ab66fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_51aa98cb-0a7c-4652-9b68-ff4a5e6d286e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2fbc79da-51c6-40cb-b003-31cc9e92435c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_51aa98cb-0a7c-4652-9b68-ff4a5e6d286e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_da353eca-c3dc-4dc2-bf7e-d22ca5f09df8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6c7f3ada-e23a-4b6e-a536-b1112144ac3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_da353eca-c3dc-4dc2-bf7e-d22ca5f09df8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6c7f3ada-e23a-4b6e-a536-b1112144ac3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_110e3e69-dc69-46ba-bcf7-c68ee63df322" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_da353eca-c3dc-4dc2-bf7e-d22ca5f09df8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_110e3e69-dc69-46ba-bcf7-c68ee63df322" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentSummaryofpropertyandequipmentDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#PropertyandequipmentSummaryofpropertyandequipmentDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentSummaryofpropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_61931553-2651-418b-9399-6357e8c30614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dc857b7e-73d7-4513-99a8-33dd8de7529b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_61931553-2651-418b-9399-6357e8c30614" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dc857b7e-73d7-4513-99a8-33dd8de7529b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f6b91e9c-c270-4adb-8d7d-4c5c3aa60a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_61931553-2651-418b-9399-6357e8c30614" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f6b91e9c-c270-4adb-8d7d-4c5c3aa60a26" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryofleasecostsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesSummaryofleasecostsDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_d55fe47e-39fa-4f9f-9896-450d3b412e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_1fa3708d-9d50-4807-ae64-1c918c231abd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d55fe47e-39fa-4f9f-9896-450d3b412e4a" xlink:to="loc_us-gaap_OperatingLeaseCost_1fa3708d-9d50-4807-ae64-1c918c231abd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_aa456bab-3d8a-4518-b577-65456e757183" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d55fe47e-39fa-4f9f-9896-450d3b412e4a" xlink:to="loc_us-gaap_SubleaseIncome_aa456bab-3d8a-4518-b577-65456e757183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_0dd6893e-a25f-4a1f-a81e-aa4974f9c56f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d55fe47e-39fa-4f9f-9896-450d3b412e4a" xlink:to="loc_us-gaap_VariableLeaseCost_0dd6893e-a25f-4a1f-a81e-aa4974f9c56f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesSummaryoffutureleasepaymentsDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60ae78de-a772-45ed-b295-cf8fcfda4dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f0a21010-ed5a-467f-a353-c8289cfd1e28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60ae78de-a772-45ed-b295-cf8fcfda4dc6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f0a21010-ed5a-467f-a353-c8289cfd1e28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5b35355c-f908-4a0f-a613-07283864cca5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60ae78de-a772-45ed-b295-cf8fcfda4dc6" xlink:to="loc_us-gaap_OperatingLeaseLiability_5b35355c-f908-4a0f-a613-07283864cca5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails_1" xlink:type="simple" xlink:href="cccc-20231231.xsd#LeasesSummaryoffutureleasepaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_84db7628-f5f9-4d73-904e-570191e4311d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b4d86f98-9d26-4fad-b167-26e85cf90007" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_84db7628-f5f9-4d73-904e-570191e4311d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b4d86f98-9d26-4fad-b167-26e85cf90007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a13192a0-edb5-4fe5-a3cb-f9087fbdad74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_84db7628-f5f9-4d73-904e-570191e4311d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a13192a0-edb5-4fe5-a3cb-f9087fbdad74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8490573c-f395-43a6-88ea-48e2c626be13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_84db7628-f5f9-4d73-904e-570191e4311d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8490573c-f395-43a6-88ea-48e2c626be13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ac8bb0ef-9040-41e3-b2dc-e5f90d8edbae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_84db7628-f5f9-4d73-904e-570191e4311d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ac8bb0ef-9040-41e3-b2dc-e5f90d8edbae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4e0b278a-e48a-4806-a78a-9a69d039de6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_84db7628-f5f9-4d73-904e-570191e4311d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4e0b278a-e48a-4806-a78a-9a69d039de6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8f1b4a24-56e2-41fb-9e63-41a0af874d93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_84db7628-f5f9-4d73-904e-570191e4311d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8f1b4a24-56e2-41fb-9e63-41a0af874d93" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#AccruedexpensesandothercurrentliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_ccee348a-dd96-4d22-8dc9-54706fe919a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AccruedResearchAndDevelopmentCurrent_40de0232-5e29-489c-b901-86611b81a3cc" xlink:href="cccc-20231231.xsd#cccc_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_ccee348a-dd96-4d22-8dc9-54706fe919a8" xlink:to="loc_cccc_AccruedResearchAndDevelopmentCurrent_40de0232-5e29-489c-b901-86611b81a3cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_ff49de5d-ba2c-4574-98c3-935b0e3e667c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_ccee348a-dd96-4d22-8dc9-54706fe919a8" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_ff49de5d-ba2c-4574-98c3-935b0e3e667c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_dba992dd-da6e-4db0-9d21-6ac9fd28e221" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_ccee348a-dd96-4d22-8dc9-54706fe919a8" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_dba992dd-da6e-4db0-9d21-6ac9fd28e221" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ae7c5715-efe2-44a3-9285-45b57699d4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e4d9557f-0306-4b17-b740-926e6b02f6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_ae7c5715-efe2-44a3-9285-45b57699d4ae" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e4d9557f-0306-4b17-b740-926e6b02f6fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_335f8700-7b99-4c36-a63d-22678e33d108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_ae7c5715-efe2-44a3-9285-45b57699d4ae" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_335f8700-7b99-4c36-a63d-22678e33d108" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyScheduleoflongtermdebtDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#LongtermdebtandwarrantrelatedpartyScheduleoflongtermdebtDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyScheduleoflongtermdebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_74c35778-9831-45dc-a097-dc273f8d85a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a08a05c0-619a-42dc-9d32-162e49f288c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_74c35778-9831-45dc-a097-dc273f8d85a7" xlink:to="loc_us-gaap_LongTermDebtCurrent_a08a05c0-619a-42dc-9d32-162e49f288c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3dd96c81-96b3-47c0-873c-fb9839c89e59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_74c35778-9831-45dc-a097-dc273f8d85a7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3dd96c81-96b3-47c0-873c-fb9839c89e59" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesSummaryofincometaxbenefitexpenseDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#IncometaxesSummaryofincometaxbenefitexpenseDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/IncometaxesSummaryofincometaxbenefitexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_116e7b7b-0259-4f9a-b160-509229ce30ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_93d45ce3-cab0-4b10-8078-2e04819bd884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_116e7b7b-0259-4f9a-b160-509229ce30ae" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_93d45ce3-cab0-4b10-8078-2e04819bd884" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_34b217b9-a5b4-470d-ad9b-d1fb87fc275c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_116e7b7b-0259-4f9a-b160-509229ce30ae" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_34b217b9-a5b4-470d-ad9b-d1fb87fc275c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f5167ceb-f8f1-4af8-b5ee-16452047ba0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_116e7b7b-0259-4f9a-b160-509229ce30ae" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f5167ceb-f8f1-4af8-b5ee-16452047ba0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_763c9c44-64a7-4024-b0f7-8bed9728aa3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6aba64f6-0d2e-44ab-a4ba-4893625f476a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_763c9c44-64a7-4024-b0f7-8bed9728aa3d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6aba64f6-0d2e-44ab-a4ba-4893625f476a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_482f694c-1e04-496a-a23e-522e8a66dadc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_763c9c44-64a7-4024-b0f7-8bed9728aa3d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_482f694c-1e04-496a-a23e-522e8a66dadc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f62bc3e7-a253-4c87-b199-1173b5f0f504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_763c9c44-64a7-4024-b0f7-8bed9728aa3d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f62bc3e7-a253-4c87-b199-1173b5f0f504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_f50b44d0-a265-42c7-8991-0988f007d724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_763c9c44-64a7-4024-b0f7-8bed9728aa3d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_f50b44d0-a265-42c7-8991-0988f007d724" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesScheduleofeffectiveincometaxratereconciliationDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#IncometaxesScheduleofeffectiveincometaxratereconciliationDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/IncometaxesScheduleofeffectiveincometaxratereconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f8ea9075-ec58-4013-92e2-7d413567afa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f8ea9075-ec58-4013-92e2-7d413567afa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_c284b038-7ced-4081-bd77-62d3f16ef156" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_c284b038-7ced-4081-bd77-62d3f16ef156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_33dd3031-06d6-477e-a9e3-d5bef6f35810" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_33dd3031-06d6-477e-a9e3-d5bef6f35810" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit_1d43a0fa-2415-4142-b178-d4509317a130" xlink:href="cccc-20231231.xsd#cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit_1d43a0fa-2415-4142-b178-d4509317a130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit_e98a562a-3d81-4420-aec3-99e7a4e5c5f9" xlink:href="cccc-20231231.xsd#cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit_e98a562a-3d81-4420-aec3-99e7a4e5c5f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7d7de5ea-6dd6-48d2-8168-e0e61117702c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7d7de5ea-6dd6-48d2-8168-e0e61117702c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_65b4f00e-4ceb-4bc5-afbf-2a9a08a035ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_65b4f00e-4ceb-4bc5-afbf-2a9a08a035ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationWithholdingTax_b533e553-8531-409d-802a-e3f83c3baa8e" xlink:href="cccc-20231231.xsd#cccc_EffectiveIncomeTaxRateReconciliationWithholdingTax"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_23700534-57d1-4ff6-9d39-0e03a169e392" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationWithholdingTax_b533e553-8531-409d-802a-e3f83c3baa8e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesScheduleofdeferredtaxassetsandliabilitiesDetails" xlink:type="simple" xlink:href="cccc-20231231.xsd#IncometaxesScheduleofdeferredtaxassetsandliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://c4therapeutics.com/role/IncometaxesScheduleofdeferredtaxassetsandliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsCapitalizedStartUpCosts_20d5aa19-8c82-4948-989c-eb47124b7034" xlink:href="cccc-20231231.xsd#cccc_DeferredTaxAssetsCapitalizedStartUpCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_cccc_DeferredTaxAssetsCapitalizedStartUpCosts_20d5aa19-8c82-4948-989c-eb47124b7034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsOperatingLeaseLiability_f3d1a5ca-2dd5-4bce-b8ec-43c698065133" xlink:href="cccc-20231231.xsd#cccc_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_cccc_DeferredTaxAssetsOperatingLeaseLiability_f3d1a5ca-2dd5-4bce-b8ec-43c698065133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c9595f96-0e54-47b2-9b5b-3904252d377b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c9595f96-0e54-47b2-9b5b-3904252d377b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b8e99ee5-7ec0-4aea-acd6-859340e854e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b8e99ee5-7ec0-4aea-acd6-859340e854e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8f06fb15-9477-4f13-b890-a35d42336e02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8f06fb15-9477-4f13-b890-a35d42336e02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_963400d5-d027-4983-b2f3-c74412451d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_963400d5-d027-4983-b2f3-c74412451d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_57760d79-3e50-4a78-b59a-621f156ae90a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_57760d79-3e50-4a78-b59a-621f156ae90a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_ff022750-1409-489f-97d9-793acd03a265" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_ff022750-1409-489f-97d9-793acd03a265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_ba998820-2585-40ff-8d19-d74d66e260d6" xlink:href="cccc-20231231.xsd#cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_ba998820-2585-40ff-8d19-d74d66e260d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_633696f8-90fe-4620-a39a-47e440934274" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d8e91550-0b43-4d6f-b449-45c0d5a27b56" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_633696f8-90fe-4620-a39a-47e440934274" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_3620c9ae-0b61-44c3-80f8-bde340e9f937" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9b6392f5-305f-451b-af4a-e610c6b28eec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_3620c9ae-0b61-44c3-80f8-bde340e9f937" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9b6392f5-305f-451b-af4a-e610c6b28eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxLiabilitiesRightOfUseAsset_147ff302-5643-439d-b90d-7eca584ea0f8" xlink:href="cccc-20231231.xsd#cccc_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_3620c9ae-0b61-44c3-80f8-bde340e9f937" xlink:to="loc_cccc_DeferredTaxLiabilitiesRightOfUseAsset_147ff302-5643-439d-b90d-7eca584ea0f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_4e25c7b9-b649-48c6-943e-7ff5fe97c4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_3620c9ae-0b61-44c3-80f8-bde340e9f937" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_4e25c7b9-b649-48c6-943e-7ff5fe97c4fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_f1c352f5-21e8-428c-ae10-729718d0b469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_3620c9ae-0b61-44c3-80f8-bde340e9f937" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_f1c352f5-21e8-428c-ae10-729718d0b469" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
